OKYO Pharma receives FDA feedback on phase 3 neuropathic pain trial

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A ImmunityBio secures exclusive U.S. rights to Tokyo BCG strain Hisse Senetleri 0 34
A Core inflation in Tokyo stays below BOJ’s target in March Hisse Senetleri 0 46
A Tokyo CPI inflation hits four-year low in March Hisse Senetleri 0 32
A Form 6K Tokyo Lifestyle Co. For: 6 March Hisse Senetleri 0 27
A Tokyo’dan Tayvan’a Yakın Adalara Güvenlik Hamlesi Gündem'den Güncel 0 38
A Trump says Indo-Pacific energy meeting to be held in Tokyo in March Hisse Senetleri 0 26
A Japan-US alliance would crumble if Tokyo ignored Taiwan crisis, PM Takaichi says Hisse Senetleri 0 29
A OKYO Pharma stock gets FDA compassionate use approval for urcosimod Hisse Senetleri 0 48

Benzer konular

Üst